South Africa halts AstraZeneca vaccine plan over study data
Published
Trial shows Oxford-developed COVID-19 vaccine offers only "minimal" protection against mild to moderate illness from South Africa variant.
Full ArticlePublished
Trial shows Oxford-developed COVID-19 vaccine offers only "minimal" protection against mild to moderate illness from South Africa variant.
Full ArticleSouth Africa's Covid-19 vaccine rollout plan has practically changed overnight after a small study's results showed that the..